
Aignostics is an AI-powered company transforming drug development and improving patient outcomes through precision medicine. They offer a range of products including Foundation Models and the Atlas H&E-TME profiling application, supported by custom services for target and biomarker discovery, translational research, and digital diagnostics. The company emphasizes its deep biomedical expertise, advanced machine learning capabilities, and collaborations with academic institutions. Aignostics, a spin-off from Charité Berlin, has offices in Berlin and New York, and is certified with ISO 13485 and 27001, with a GCP-ready clinical trial platform. They have raised $55 million in funding and employ over 120 people.

Aignostics is an AI-powered company transforming drug development and improving patient outcomes through precision medicine. They offer a range of products including Foundation Models and the Atlas H&E-TME profiling application, supported by custom services for target and biomarker discovery, translational research, and digital diagnostics. The company emphasizes its deep biomedical expertise, advanced machine learning capabilities, and collaborations with academic institutions. Aignostics, a spin-off from Charité Berlin, has offices in Berlin and New York, and is certified with ISO 13485 and 27001, with a GCP-ready clinical trial platform. They have raised $55 million in funding and employ over 120 people.
Headquarters: Berlin and New York
Founded: 2018 (spun out 2020)
Sector: AI-powered computational pathology / biotechnology
Recent raise: $34M Series B (Oct 29, 2024)
Total disclosed funding: ≈ $55M
Employees: ≈ 137
| Company |
|---|
Translating complex biomedical imaging data into actionable insights for precision medicine and drug development.
2018
Biotechnology
€5,000,000
€14,000,000
$34,000,000
Participants included Mayo Clinic, HTGF and existing investors
“Includes strategic and healthcare-focused investors such as ATHOS, Mayo Clinic, Wellington Partners, Boehringer Ingelheim Venture Fund, HTGF and IBB Ventures”
We believe that AI has the potential to revolutionize how cancer and other complex diseases are diagnosed and treated. We also believe that AI is a tool, not an identity – without access to high quality data and a scientifically rigorous, transparent approach to model development, AI is just a buzzword. That’s where we come in.
Aignostics is a spin-off from one of Europe's largest and most prestigious university hospitals (Charité), with employees in Berlin and New York. We have received over $50M in funding from leading investors and are a growing team of over 100 interdisciplinary professionals. We work with academic partners as well as leading global life sciences companies.
As a QM Specialist (CAPA and Change Management) you'll own the development and execution of our corrective and preventive action (CAPA) systems and change management processes—ensuring quality issues are systematically resolved, product changes are implemented swiftly yet compliantly, and that our organization continuously learns and improves. Your work directly impacts our ability to deliver transformative healthcare solutions to patients worldwide. In this strategic position, you'll be instrumental in maintaining our ISO 13485 certification and ensuring that our cutting-edge AI products meet the highest quality and regulatory standards.
This is a unique opportunity to join a fun, diverse, and growing team of 100+ data scientists, software developers, biologists, and pathologists to shape the next generation of cancer treatments. You will be part of a driven community that works in an agile, supportive and interdisciplinary research environment where your results make a difference to patients. In our established startup you have the opportunity to grow personally and technically, take responsibility and benefit from a dynamic work environment.
At Aignostics, we believe that fighting cancer is a job for people of all identities, backgrounds, and cultures. We value and celebrate diversity and inclusion and are committed to offering equal employment and promotion opportunities for all applicants and employees. Applicants will be considered regardless of their age, disability, ethnicity, race, gender identity or expression, sexual orientation, religion, etc. We thrive through collaboration and believe the more inclusive we are, the better our work will be.
Where your expertise is needed Build Robust Quality Systems
Enable Cross-Functional Excellence
Foster a Learning Culture
What We Are Looking For
Our offer
Join us to make a difference!
We are an international, interdisciplinary team that is powering the next generation of precision medicine and advancing the fields of AI and pathology.